Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Netherlands. redekop@bmg.eur.nlAIMS: The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabetes, examine which patient and/or treatment characteristics are associated with costs, and estimate the medical and non-medical costs of patients with Type 2 diabetes in The Netherlands. METHODS: Twenty-nine Dutch general practitioners provided information on all Type 2 diabetes patients in their practice (n = 1371), information on demography, clinical characteristics, treatment type, the presence of complications and the type and amount of medical consumption during the previous 6 months. Medical costs were analysed...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
OBJECTIVES: To estimate the total direct medical costs to society for patients with type 2 diabetes ...
Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Net...
Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Net...
Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Net...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Independent determinants of the medical costs of Type 2 diabetes in The Netherlands include age, com...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
OBJECTIVES: To estimate the total direct medical costs to society for patients with type 2 diabetes ...
Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Net...
Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Net...
Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, The Net...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Aims The aims of this study were to estimate the costs incurred by Dutch patients with Type 2 diabet...
Independent determinants of the medical costs of Type 2 diabetes in The Netherlands include age, com...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
Objectives The aim of this study was to describe the healthcare utilization and expenditures related...
OBJECTIVES: To estimate the total direct medical costs to society for patients with type 2 diabetes ...